Bis((1,4,7,10,13-pentaoxacyclopentadecan-2-yl)methyl) 2-dodecyl-2-methylmalonate

Catalog No. :
ACBACF794
CAS No. :
87505-87-1
Molecular Formula :
C38H70O14
Molecular Weight :
750.96

IUPAC Name:bis((1,4,7,10,13-pentaoxacyclopentadecan-2-yl)methyl) 2-dodecyl-2-methylmalonate

Bis((1,4,7,10,13-pentaoxacyclopentadecan-2-yl)methyl) 2-dodecyl-2-methylmalonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBis((1,4,7,10,13-pentaoxacyclopentadecan-2-yl)methyl) 2-dodecyl-2-methylmalonate
IUPAC Namebis((1,4,7,10,13-pentaoxacyclopentadecan-2-yl)methyl) 2-dodecyl-2-methylmalonate
Molecular FormulaC38H70O14
Molecular Weight750.96
SMILESO=C(OCC1OCCOCCOCCOCCOC1)C(C)(CCCCCCCCCCCC)C(OCC2OCCOCCOCCOCCOC2)=O
InChI KeyVBSJDFMINZMRTI-UHFFFAOYSA-N
SynonymBis-[(15-crown-5)-methyl-2-dodecyl-2-methylmalonate;Bis((1,4,7,10,13-pentaoxacyclopentadecan-2-yl)methyl) 2-dodecyl-2-methylmalonate;Name:Bis(1,4,7,10,13-pentaoxacyclopentadecan-2-yl)methyl)2-dodecyl-2-methylmalonate;dodecylmethylmalonate of bis(15-crown-5);Propanedioic acid, 2-dodecyl-2-methyl-, 1,3-bis(1,4,7,10,13-pentaoxacyclopentadec-2-ylmethyl) ester
CAS No.87505-87-1

Synthetic Route by SureRoute

1. ACBACF794 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTIPA918 route compound structure diagram
    ACTIPA91875507-25-4 In Stock
  4. Then
  5. ACBACF794 route product structure diagram
    ACBACF79487505-87-1
Inquiry

2. ACBACF794 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTIPA918 route compound structure diagram
    ACTIPA91875507-25-4 In Stock
  4. Then
  5. ACBACF794 route product structure diagram
    ACBACF79487505-87-1
Inquiry

Comments (0)